Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Starr

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Brain Research|February 18, 2018
Synaptic dysfunction and altered excitability in C9ORF72 ALS/FTDAlexander Starr, Rita Sattler
Viruses|July 2, 2021
Confound, Cause, or Cure: The Effect of Cannabinoids on HIV-Associated Neurological SequelaeAlexander Starr, Kelly L Jordan-Sciutto, Eugene Mironets
Frontiers in Neuroscience|February 27, 2018
Representing Diversity in the Dish: Using Patient-Derived <i>in Vitro</i> Models to Recreate the Heterogeneity of Neurological DiseaseLayla T Ghaffari, Alexander Starr, Andrew T Nelson, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 15, 2011
Bortezomib (Velcade), rituximab, cyclophosphamide, and dexamethasone combination regimen is active as front-line therapy of low-grade non-Hodgkin lymphomaChadi Nabhan, Dana Villines, Neil Dalal, et al.
Frontiers in Molecular Neuroscience|February 13, 2024
Human iPSC-derived neurons reveal NMDAR-independent dysfunction following HIV-associated insultsAlexander Starr, Emily Nickoloff-Bybel, Razan Abedalthaqafi, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|October 11, 2025
Differential Effects of Cannabinoid Receptor 2 Agonists on HIV Replication and Inflammatory Activation in Monocyte-Derived Macrophages and Induced Pluripotent Stem Cell-Derived MicrogliaAlexander Starr, Sara Rathore, Marzieh Daniali, et al.
Cancer|April 15, 2006
Phase II study of mitoxantrone and ketoconazole for hormone-refractory prostate cancerJohn Eklund, Mark Kozloff, Joy Vlamakis, et al.
Cell Reports|October 6, 2017
Post-transcriptional Inhibition of Hsc70-4/HSPA8 Expression Leads to Synaptic Vesicle Cycling Defects in Multiple Models of ALSAlyssa N Coyne, Ileana Lorenzini, Ching-Chieh Chou, et al.
Elife|June 11, 2019
Glycolysis upregulation is neuroprotective as a compensatory mechanism in ALSErnesto Manzo, Ileana Lorenzini, Dianne Barrameda, et al.
Acta Neuropathologica|September 28, 2019
Correction to: ADAR2 mislocalization and widespread RNA editing aberrations in C9orf72-mediated ALS/FTDStephen Moore, Eric Alsop, Ileana Lorenzini, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Brain Research|February 18, 2018
Synaptic dysfunction and altered excitability in C9ORF72 ALS/FTDAlexander Starr, Rita Sattler
Viruses|July 2, 2021
Confound, Cause, or Cure: The Effect of Cannabinoids on HIV-Associated Neurological SequelaeAlexander Starr, Kelly L Jordan-Sciutto, Eugene Mironets
Frontiers in Neuroscience|February 27, 2018
Representing Diversity in the Dish: Using Patient-Derived <i>in Vitro</i> Models to Recreate the Heterogeneity of Neurological DiseaseLayla T Ghaffari, Alexander Starr, Andrew T Nelson, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 15, 2011
Bortezomib (Velcade), rituximab, cyclophosphamide, and dexamethasone combination regimen is active as front-line therapy of low-grade non-Hodgkin lymphomaChadi Nabhan, Dana Villines, Neil Dalal, et al.
Frontiers in Molecular Neuroscience|February 13, 2024
Human iPSC-derived neurons reveal NMDAR-independent dysfunction following HIV-associated insultsAlexander Starr, Emily Nickoloff-Bybel, Razan Abedalthaqafi, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|October 11, 2025
Differential Effects of Cannabinoid Receptor 2 Agonists on HIV Replication and Inflammatory Activation in Monocyte-Derived Macrophages and Induced Pluripotent Stem Cell-Derived MicrogliaAlexander Starr, Sara Rathore, Marzieh Daniali, et al.
Cancer|April 15, 2006
Phase II study of mitoxantrone and ketoconazole for hormone-refractory prostate cancerJohn Eklund, Mark Kozloff, Joy Vlamakis, et al.
Cell Reports|October 6, 2017
Post-transcriptional Inhibition of Hsc70-4/HSPA8 Expression Leads to Synaptic Vesicle Cycling Defects in Multiple Models of ALSAlyssa N Coyne, Ileana Lorenzini, Ching-Chieh Chou, et al.
Elife|June 11, 2019
Glycolysis upregulation is neuroprotective as a compensatory mechanism in ALSErnesto Manzo, Ileana Lorenzini, Dianne Barrameda, et al.
Acta Neuropathologica|September 28, 2019
Correction to: ADAR2 mislocalization and widespread RNA editing aberrations in C9orf72-mediated ALS/FTDStephen Moore, Eric Alsop, Ileana Lorenzini, et al.
Pageof 2